QTREX management to buy 2M shares over 12 months
QTREX Quantum Ltd. announced that its CEO, Chairman, and senior management intend to purchase up to 2,000,000 ordinary shares over the next 12 months using personal funds, starting June 22, 2026. Purchases will begin after the release of financial results for the period ending June 30, 2026, subject to insider trading policies and market conditions. The company continues to focus on its Additively Manufactured Electronics strategy for quantum computing infrastructure.

*this image is generated using AI for illustrative purposes only.
QTREX Quantum Ltd. announced that Dagi Ben-Noon, Chief Executive Officer, Tal Parnas, Chairman of the Board of Directors, and members of the senior management team intend to purchase up to an aggregate of 2,000,000 ordinary shares using personal funds. The share purchase plan covers a period of 12 months starting June 22, 2026, and is subject to applicable rules, regulations, and the Company’s insider trading policy.
The actual share purchases will commence following the release of the Company’s financial results for the period ending June 30, 2026. The plan remains subject to blackout periods, reporting obligations, and any applicable trading plan requirements. Management expects to execute these purchases primarily through open-market transactions at prevailing market prices, depending on market conditions. Transactions may also occur through privately negotiated deals, block trades, or other legally permissible means.
QTREX continues to advance its Additively Manufactured Electronics (AME) strategy for quantum computing infrastructure. The Company focuses on cryogenic interconnect applications, cryogenic chip carrier development, advanced materials, and strategic industry collaborations. QTREX stated it will update shareholders on material business milestones as appropriate.
About QTREX Quantum
QTREX Quantum Ltd. is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company develops high-density, thermally optimized quantum connectivity solutions for dilution cryostats. It also advances AME applications for defense, aerospace, missile, space, and other mission-critical environments. Additionally, QTREX is working to monetize parts of its medical technology portfolio, which includes respiratory support and blood monitoring platforms.
What specific material business milestones does QTREX anticipate achieving before the share purchase plan commences in June 2026?
How will the monetization of the medical technology portfolio impact the company's focus and resource allocation toward quantum computing infrastructure?
What strategic industry collaborations is QTREX currently pursuing to advance its Additively Manufactured Electronics (AME) strategy?



























